Total Payments
$12,522
2024 Payments
$963.31
Companies
44
Transactions
726
Medicare Patients
4,506
Medicare Billing
$652,885
Payment Breakdown by Category
Food & Beverage$12,479 (99.7%)
Education$42.94 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,479 | 722 | 99.7% |
| Education | $42.94 | 4 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,704 | 128 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,360 | 54 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,340 | 72 | $0 (2024) |
| Electromed, Inc. | $929.78 | 90 | $0 (2024) |
| United Therapeutics Corporation | $589.02 | 31 | $0 (2024) |
| Insmed, Inc. | $540.16 | 20 | $0 (2024) |
| Philips Electronics North America Corporation | $535.70 | 28 | $0 (2023) |
| Genentech USA, Inc. | $519.03 | 34 | $0 (2023) |
| GENZYME CORPORATION | $479.12 | 24 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $473.68 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $963.31 | 55 | Electromed, Inc. ($139.62) |
| 2023 | $1,586 | 85 | Electromed, Inc. ($310.65) |
| 2022 | $2,134 | 123 | GlaxoSmithKline, LLC. ($224.46) |
| 2021 | $1,770 | 96 | GlaxoSmithKline, LLC. ($260.65) |
| 2020 | $1,358 | 63 | Philips Electronics North America Corporation ($204.99) |
| 2019 | $1,450 | 84 | AstraZeneca Pharmaceuticals LP ($240.34) |
| 2018 | $1,569 | 116 | AstraZeneca Pharmaceuticals LP ($293.67) |
| 2017 | $1,691 | 104 | GlaxoSmithKline, LLC. ($400.74) |
All Payment Transactions
726 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $11.03 | General |
| Category: HFCWO | ||||||
| 08/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $27.59 | General |
| Category: RESPIRATORY | ||||||
| 08/26/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Respiratory | ||||||
| 08/23/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $9.32 | General |
| Category: HFCWO | ||||||
| 08/15/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $6.32 | General |
| Category: HFCWO | ||||||
| 08/13/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $30.16 | General |
| Category: Cardiology | ||||||
| 08/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Immunology | ||||||
| 08/07/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 08/06/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $7.09 | General |
| Category: HFCWO | ||||||
| 08/06/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $4.61 | General |
| Category: IMMUNOLOGY | ||||||
| 08/06/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $4.18 | General |
| Category: IMMUNOLOGY | ||||||
| 08/01/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $32.76 | General |
| Category: Respiratory | ||||||
| 08/01/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $8.73 | General |
| Category: HFCWO | ||||||
| 08/01/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $6.56 | General |
| Category: HFCWO | ||||||
| 08/01/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $1.31 | General |
| Category: HFCWO | ||||||
| 08/01/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $1.11 | General |
| Category: HFCWO | ||||||
| 07/31/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: IMMUNOLOGY | ||||||
| 07/17/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $11.88 | General |
| Category: HFCWO | ||||||
| 07/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $31.03 | General |
| Category: RESPIRATORY | ||||||
| 07/15/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/19/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $5.50 | General |
| Category: HFCWO | ||||||
| 04/18/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $27.60 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 04/15/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Inflammation | ||||||
| 04/13/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $15.19 | General |
| Category: HFCWO | ||||||
| 04/11/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $30.78 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,119 | 2,061 | $418,132 | $157,281 |
| 2022 | 13 | 1,260 | 2,282 | $438,180 | $166,298 |
| 2021 | 14 | 1,218 | 2,372 | $458,338 | $179,630 |
| 2020 | 13 | 909 | 1,832 | $391,400 | $149,677 |
Total Patients
4,506
Total Services
8,547
Medicare Billing
$652,885
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 168 | 755 | $110,581 | $45,719 | 41.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 237 | 394 | $85,104 | $34,593 | 40.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 88 | 216 | $48,582 | $19,296 | 39.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 118 | 125 | $51,850 | $16,568 | 32.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 93 | 93 | $38,502 | $14,347 | 37.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 28 | 53 | $29,337 | $8,231 | 28.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 43 | 55 | $15,950 | $6,605 | 41.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 81 | 84 | $9,240 | $3,209 | 34.7% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 75 | 78 | $8,268 | $2,922 | 35.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 83 | 87 | $10,788 | $2,337 | 21.7% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 52 | 66 | $3,696 | $1,569 | 42.5% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 13 | 13 | $4,022 | $1,273 | 31.7% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 28 | 28 | $2,072 | $493.92 | 23.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 12 | 14 | $140.00 | $117.60 | 84.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 261 | 480 | $103,680 | $43,709 | 42.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 164 | 635 | $92,827 | $35,031 | 37.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 100 | 343 | $73,896 | $27,237 | 36.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 119 | 119 | $49,266 | $16,854 | 34.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 109 | 111 | $45,176 | $16,354 | 36.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 42 | 51 | $14,790 | $6,890 | 46.6% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 98 | 112 | $12,320 | $4,909 | 39.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 17 | 28 | $14,805 | $4,754 | 32.1% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 99 | 113 | $11,978 | $4,670 | 39.0% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 108 | 124 | $9,176 | $2,505 | 27.3% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 70 | 83 | $4,648 | $2,032 | 43.7% |
About Dr. Cameron Dick, MD
Dr. Cameron Dick, MD is a Pulmonary Disease healthcare provider based in Phoenix, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1194780767.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Cameron Dick, MD has received a total of $12,522 in payments from pharmaceutical and medical device companies, with $963.31 received in 2024. These payments were reported across 726 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($12,479).
As a Medicare-enrolled provider, Dick has provided services to 4,506 Medicare beneficiaries, totaling 8,547 services with total Medicare billing of $652,885. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Phoenix, AZ
- Active Since 04/18/2006
- Last Updated 08/31/2010
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1194780767
Products in Payments
- SMARTVEST (Device) $929.78
- OFEV (Drug) $898.87
- DUPIXENT (Biological) $849.01
- TRELEGY ELLIPTA (Drug) $751.08
- Arikayce (Drug) $523.92
- NUCALA (Biological) $411.27
- (8874) inCourage (Device) $375.44
- SYMBICORT (Drug) $340.29
- BREZTRI (Drug) $320.22
- Xolair (Biological) $318.93
- GLASSIA (Biological) $318.07
- STIOLTO RESPIMAT (Drug) $305.42
- TYVASO (Drug) $301.01
- FASENRA (Drug) $298.73
- OPSUMIT (Drug) $261.46
- ANORO (Drug) $248.59
- TEZSPIRE (Biological) $212.53
- UPTRAVI (Drug) $211.02
- Esbriet (Biological) $200.10
- BREO (Drug) $198.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Phoenix
Mr. Tony Hodges, M.d, M.D
Pulmonary Disease — Payments: $553,075
Pulmonary Disease $553,075
Dr. Rajeev Saggar, Md, MD
Pulmonary Disease — Payments: $314,060
Pulmonary Disease $314,060
Da-Wei Liao, Md, MD
Pulmonary Disease — Payments: $287,386
Pulmonary Disease $287,386
Michael Zgoda, Md, MD
Pulmonary Disease — Payments: $57,959
Pulmonary Disease $57,959
Syed Shahryar, M.d, M.D
Pulmonary Disease — Payments: $27,446
Pulmonary Disease $27,446
Sunil Santhanakrishnan, Md, MD
Pulmonary Disease — Payments: $24,418
Pulmonary Disease $24,418